Related Experiment Video
Updated: Aug 17, 2026

Ex Vivo Organotypic Corneal Model of Acute Epithelial Herpes Simplex Virus Type I Infection
Published on: November 3, 2012
Treatment of herpes labialis with acyclovir. Review of three clinical trials
G W Raborn1, W T McGaw, M Grace
1Faculty of Dentistry, University of Alberta, Edmonton, Canada.
Abstract:
Three trials with acyclovir in the treatment of recurrent herpes labialis in the same patient population are reviewed. In the first trial, oral acyclovir capsules, five times per day for five days, were shown to be of significant benefit for some parameters of cutaneous resolution in three successive episodes. Topical formulations were evaluated in two separate trials; 5 percent acyclovir in a modified aqueous cream base exhibited favorable trends, but 5 percent acyclovir in a polyethylene base was ineffective. A high dose of oral acyclovir may offer the most effective method of control of recurrent herpes labialis.
Related Concept Videos
DNA Base Pairing
Clinical Trials: Overview
Acne Infection
Herpes
Genital Herpes
Antiviral Nucleoside Inhibitors

